Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|December 23, 2011
Successful surgical repair of a giant calcified left ventricular aneurysm: a report of a caseYukiharu Sugimura, Masaaki Toyama, Masanori Katoh, et al.
Antiviral Chemistry & Chemotherapy|November 4, 2017
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitorsMasanori Baba, Masaaki Toyama, Norikazu Sakakibara, et al.
Nucleic Acids Symposium Series (2004)|November 22, 2007
Suppression of subgenomic hepatitis C virus replication by 5'-O-masked analogues of 6-chloropurine-2'-deoxyribosideMasahiro Ikejiri, Takayuki Ohshima, Keizo Kato, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agentsMasahiro Ikejiri, Takayuki Ohshima, Keizo Kato, et al.
Anticancer Research|July 4, 2012
Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivativeMasaaki Toyama, Takayuki Hamasaki, Tomofumi Uto, et al.
Immunology Letters|June 23, 2011
Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in miceTomofumi Uto, Takami Akagi, Masaaki Toyama, et al.
Results in Immunology|March 7, 2014
Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivoTomofumi Uto, Masaaki Toyama, Yosuke Nishi, et al.
Antiviral Research|August 26, 2015
Selective inhibition of HIV-1 replication by the CDK9 inhibitor FIT-039Mika Okamoto, Akemi Hidaka, Masaaki Toyama, et al.
Chest|June 18, 2002
Vocal cord paralysis after surgery for thoracic aortic aneurysmShin-Ichi Ishimoto, Ken Ito, Masaaki Toyama, et al.
RSC Medicinal Chemistry|February 24, 2025
Pyrazolo[3,4-d]pyrimidine-based neplanocin analogues identified as potential de novo pharmacophores for dual-target HBV inhibitionMohan Kasula, Masaaki Toyama, Ramakrishnamraju Samunuri, et al.
Pageof 6